Fludeoxyglucose F 18

FDA Drug Profile — Fludeoxyglucose F 18

Fludeoxyglucose F 18 is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand name including Fludeoxyglucose F 18. Available dosage forms: injection, injection, solution.

Drug details

Generic Name
Fludeoxyglucose F 18
Brand Names
Fludeoxyglucose F 18
Application Number
ANDA204463
Sponsor
SOFIE Co. Dba SOFIE
NDC Codes
7
Dosage Forms
INJECTION, INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
FLUDEOXYGLUCOSE F-18

Indications and Usage

1 INDICATIONS AND USAGE Fludeoxyglucose F 18 Injection is indicated for positron emission tomography (PET) imaging in the following settings: Fludeoxyglucose F 18 Injection is indicated for positron emission tomography (PET) imaging in the following settings: Oncology: For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. Cardiology: For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. Neurology: For the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures ( 1 ). 1.1 Oncology For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. 1.2 Cardiology For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. 1.3 Neurology For the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.